13 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35061800 | Cryptotanshinone inhibits proliferation and induces apoptosis of breast cancer MCF-7 cells via GPER mediated PI3K/AKT signaling pathway. | 2022 | 3 |
2 | 35462337 | Anti-tumor effects of cryptotanshinone (C19H20O3) in human osteosarcoma cell lines. | 2022 Jun | 1 |
3 | 33800264 | Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro. | 2021 Mar 8 | 2 |
4 | 31897244 | Cryptotanshinone Inhibites Bladder Cancer Cell Proliferation and Promotes Apoptosis via the PTEN/PI3K/AKT Pathway. | 2020 | 4 |
5 | 32357920 | Inhibition of PI3K/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells. | 2020 May 1 | 1 |
6 | 30535477 | Cryptotanshinone induces reactive oxygen species‑mediated apoptosis in human rheumatoid arthritis fibroblast‑like synoviocytes. | 2019 Feb | 1 |
7 | 30891815 | Cryptotanshinone inhibits hypoxia/reoxygenation-induced oxidative stress and apoptosis in renal tubular epithelial cells. | 2019 Aug | 5 |
8 | 31872599 | [Molecular mechanism of apoptosis of breast cancer SKBR-3 cells induced by cryptanshinone via G protein coupled estrogen receptor( GPER) mediated pathway]. | 2019 Nov | 1 |
9 | 30106122 | Cryptotanshinone inhibits cellular proliferation of human lung cancer cells through downregulation ofIGF-1R/PI3K/Akt signaling pathway. | 2018 Nov | 1 |
10 | 30217003 | Cryptotanshinone Induces Cell Cycle Arrest and Apoptosis of NSCLC Cells through the PI3K/Akt/GSK-3β Pathway. | 2018 Sep 13 | 2 |
11 | 28670110 | Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells. | 2017 | 3 |
12 | 26962683 | IL10 inhibits starvation-induced autophagy in hypertrophic scar fibroblasts via cross talk between the IL10-IL10R-STAT3 and IL10-AKT-mTOR pathways. | 2016 Mar 10 | 1 |
13 | 26356271 | Cryptotanshinone Reverses Cisplatin Resistance of Human Lung Carcinoma A549 Cells through Down-Regulating Nrf2 Pathway. | 2015 | 1 |